Improved Access to Quality Care and Healthcare Use

NCT06275867 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2024-10-15

No results posted yet for this study

Summary

This study is an individual-level randomised controlled trial which looks at the effect of providing free access to higher quality providers in urban South Africa. The study will recruit about 1,500 individuals with a child aged 5 or under. They will be randomly allocate to a control group (CONTROL) with the default free access to government facilities or one of the two treatment groups where they will have free access to private providers located either relatively close (CONVENIENT) by or relatively far (INCONVENIENT). The primary outcomes be overuse and underuse of healthcare services for children under 5

Conditions

  • Health Care Utilization
  • Health Knowledge, Attitudes, Practice
  • Health, Subjective

Interventions

OTHER

Free high-quality care

Participants are able to take their child to receive free consultations and treatment in a network of contracted private healthcare providers.

OTHER

Close distance

The network of contracted providers is located close to where participants live.

OTHER

Far distance

The network of contracted providers is located far to where participants live.

Sponsors & Collaborators

  • University of Witwatersrand, South Africa

    collaborator OTHER
  • London School of Economics and Political Science

    lead OTHER

Principal Investigators

  • Mylene Lagarde, PhD · London School of Economics and Political Science

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
2 Months
Max Age
6 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-01-20
Primary Completion
2024-06-10
Completion
2024-08-30

Countries

  • South Africa

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06275867 on ClinicalTrials.gov